Physician profile
Ronald Emerson
NPI 1073526356
$2,344.92
in general payments reported to CMS, 2019-2025
18 companies · $62.09 in 2025
The $62.09 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $880 · 2020: $228 · 2021: $235 · 2022: $372 · 2023: $274 · 2024: $294 · 2025: $62.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $491.81 | 2019-2021 | |
| Abbott Laboratories | $482.50 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $391.24 | 2020-2024 | Lifevest |
| Impulse Dynamics (USA) INC. | $237.09 | 2022-2025 | Optimizer, Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.41 | 2020-2024 | Jardiance |
| Amarin Pharma, INC. | $116.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $109.40 | 2023-2024 | Camzyos, Eliquis |
| Pfizer INC. | $99.77 | 2019-2024 | |
| Inari Medical, INC. | $68.58 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Irhythm Technologies, INC. | $47.56 | 2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $44.69 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $34.07 | 2024 | |
| Edwards Lifesciences Corporation | $25.83 | 2024 | Sapien 3 Ultra Resilia |
| Penumbra, INC. | $24.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $20.78 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.04 | 2019 | |
| Cardinal Health 200 LLC | $11.15 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Emerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.